622 W 168th St# ChonyNew York, NY 10032
Overview of Dr. Ghiassi-Nejad
Dr. Zahra Ghiassi-Nejad is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, The Mount Sinai Hospital, Mount Sinai Brooklyn, Mount Sinai West, Mount Sinai Beth Israel, Mount Sinai Morningside, Mount Sinai Hospital of Queens, and New York Eye and Ear Infirmary of Mount Sinai. She received her medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 3 years. She is one of 57 doctors at The Mount Sinai Hospital and one of 16 doctors at Mount Sinai Brooklyn who specialize in Radiation Oncology. She has more than 10 publications and over 200 citings.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2015 - 2019- Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2014 - 2018
- Icahn School of Medicine at Mount SinaiClass of 2013
Certifications & Licensure
NY State Medical License 2014 - 2026
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Breast and Pelvic Cancer Survivors' Preferences for Psychosexual Interventions to Address Sexual Health Concerns: A Qualitative Study.Lauren M Carney, Melanie Besculides, Ksenia Gorbenko, Julie B Schnur, Cindy Munoz
Psycho-Oncology. 2025-06-01 - 1 citationsPractical Approach to Computed Tomography Guided Online Adaptive Radiation Therapy for Abdominopelvic Tumors.David P Horowitz, Yi-Fang Wang, Albert Lee, Adam C Riegel, Jared Pasetsky
Practical Radiation Oncology. 2025-03-04 - 5 citationsDose and fractionation regimen for brachytherapy boost in cervical cancer in the US.Kristin Hsieh, Julie R Bloom, Daniel R Dickstein, Celina Hsieh, Deborah Marshall
Gynecologic Oncology. 2024-01-01
Authored Content
- Prognostic Factors and Patterns of Locoregional Failure After Surgical Resection in Patients with Cholangiocarcinoma Without Adjuvant Radiation Therapy: Optimal Field Design for Adjuvant Radiation TherapyJuly 2017
Press Mentions
For Advanced Sarcoma, Adding Lymphodepletion to HER2-Targeted CAR T-cell Therapy ExcitesApril 9th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
